MENU
+Compare
NXL
Stock ticker: NASDAQ
AS OF
Apr 16, 04:59 PM (EDT)
Price
$1.63
Change
-$0.10 (-5.78%)
Capitalization
13.84M

NXL Nexalin Technology Forecast, Technical & Fundamental Analysis

Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic... Show more

NXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for NXL with price predictions
Apr 15, 2025

Momentum Indicator for NXL turns negative, indicating new downward trend

NXL saw its Momentum Indicator move below the 0 level on March 28, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 45 similar instances where the indicator turned negative. In of the 45 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NXL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NXL entered a downward trend on April 07, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where NXL's RSI Oscillator exited the oversold zone, of 17 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 27 cases where NXL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NXL just turned positive on April 11, 2025. Looking at past instances where NXL's MACD turned positive, the stock continued to rise in of 17 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where NXL advanced for three days, in of 118 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.277) is normal, around the industry mean (23.728). P/E Ratio (0.000) is within average values for comparable stocks, (81.831). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (108.696) is also within normal values, averaging (41.794).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NXL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NXL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
NXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
1776 Yorktown
Phone
+1 832 260-0222
Employees
13
Web
https://www.nexalin.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SIEMX10.82N/A
N/A
SEI Emerging Markets Equity F (SIT)
LGOQX19.29N/A
N/A
Lord Abbett Growth Opportunities R2
VSOYX39.69N/A
N/A
Victory Sycamore Small Company Opp Y
MGFZX8.87N/A
N/A
MassMutual Global I
BINAX8.96N/A
N/A
BlackRock Infrastructure Sust Opps Inv A

NXL and Stocks

Correlation & Price change

A.I.dvisor tells us that NXL and HYPR have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NXL and HYPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NXL
1D Price
Change %
NXL100%
-2.81%
HYPR - NXL
24%
Poorly correlated
-5.05%
SAFLY - NXL
21%
Poorly correlated
N/A
RBOT - NXL
21%
Poorly correlated
+6.30%
NXGL - NXL
21%
Poorly correlated
+1.82%
GH - NXL
21%
Poorly correlated
-0.69%
More